Publications de Patrizia CARRIERI
Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER). Harm Reduction Journal 2022 ; 19 (1) : 2.
Exploring the medical cannabis prescribing behaviors of French general practitioners. Drug and Alcohol Review 2022 .
Stigma and care avoidance in people with unhealthy alcohol use: A call for research and action. Journal of Hepatology 2022 ; 77 (4) : 1221 - 1222.
Author response: Improving patient‐provider communication by reducing stigma associated with liver disease. Liver International 2022 ; 42 (12) : 2920 - 2920.
Smoking increases the risk of post-acute COVID-19 syndrome: Results from a French community-based survey. Tobacco Induced Diseases 2022 ; 20 : 59.
Medical Cannabis: Toward a New Policy and Health Model for an Ancient Medicine. Frontiers in Public Health 2022 ; 10 : 904291.
Perceived stigma, substance use and self-medication in night-shift healthcare workers: a qualitative study. BMC Health Services Research 2022 ; 22 (1) : 698.
Hepatitis B in Senegal: A Successful Infant Vaccination Program but Urgent Need to Scale Up Screening and Treatment (ANRS 12356 AmBASS survey). Hepatology Communications 2022 ; 6 (5) : 1005-1015. https://aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep4.1879
Impact of the COVID-19 crisis on healthcare workers: The need to address quality of working life issues. Respirology 2022 ; 27 (6) : 469 - 471.
Sleep quality deterioration in healthcare workers during the COVID-19 pandemic: the role of work-related factors and mental health. European Review for Medical and Pharmacological Sciences 2022 ; 26 (8) : 2648-2650.
Peer presence and familiarity as key factors to reduce cocaine intake: An effect mediated by the Subthalamic Nucleus. Psychopharmacology 2022 ; 239 (4) : 1097-1113.
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge? Journal of Hepatology 2022 ; 76 : 771-780.
Examining the Relationships between Mindfulness and Tobacco Craving Factors. Substance Use and Misuse 2022 ; 57 (4) : 656-659.
HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data). AIDS Research and Therapy 2022 ; 19 (1)
Knowledge of liver fibrosis stage among adults with NAFLD/NASH improves adherence to lifestyle changes. Liver International 2022 ; 42 (5) : 984 - 994.
Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 Hepather cohort). Clinical Nutrition 2022 ; 41 (3) : 610-619.
Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France. PLoS ONE 2022 ; 17 (3) : e0261069.
The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. The Lancet 2022 ; 399 (10319) : 61-116.
Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors. JHEP Reports Innovation in Hepatology 2022 ; 4 (6) : 100481.
A syndemic examination of injecting drug use, incarceration and multiple drug-related harms in French opioid users. International Journal of Prisoner Health 2021 ; ahead-of-print.
Sibling status, home birth, tattoos and stitches are risk factors for chronic hepatitis B virus infection in Senegalese children: A cross‐sectional survey. Journal of Viral Hepatitis 2021 ; 28 (11) : 1515-1525. https://onlinelibrary.wiley.com/doi/abs/10.1111/jvh.13589
Reasons for using cannabidiol: a cross-sectional study of French cannabidiol users. Journal of Cannabis Research 2021 ; 3 (1) : 46.
Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort). Liver International 2021 ; Online ahead of print.
Post‐HCV cure self‐reported changes in physical activity, eating behaviours, and fatigue in people living with HIV (ANRS CO13 HEPAVIH). Journal of Viral Hepatitis 2021 ; 28 (11) : 1665 - 1667.
Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV. Nature Communications 2021 ; 12 (1) : 4450.
A Twitter discourse analysis of negative feelings and stigma related to NAFLD, NASH and obesity. Liver International 2021 ; Online ahead of print.
European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease? JHEP Reports Innovation in Hepatology 2021 ; 3 (2) : 100234.
A two-component intervention to improve hand hygiene practices and promote alcohol-based hand rub use among people who inject drugs: a mixed-methods evaluation. BMC Infectious Diseases 2021 ; 21 (1) : 211.
Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France. Harm Reduction Journal 2021 ; 18 (1) : 11.
Implementation and evaluation of an educational intervention for safer injection in people who inject drugs in Europe: a multi-country mixed-methods study. International Journal of Drug Policy 2021 ; 87 : 102992.
Alcohol Use Disorder and Hepatitis C Prevention and Care in People Who Inject Drugs: The State of Play. Seminars in Liver Disease 2021 ; 41 (2) : 109-116.
Life after hepatitis C cure in HIV‐infected people who inject drugs and men who have sex with men treated with direct‐acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH). Journal of Viral Hepatitis 2020 ; 27 (12) : 1462-1472.
Risk of Severe Bacterial Infection in People Living Human Immunodeficiency Virus Infection in the Combined Antiretroviral Therapy Era. Journal of Infectious Diseases 2020 ; 222 (5) : 765-776.
“Everybody living with a chronic disease is entitled to be cured”: Challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drugs. International Journal of Drug Policy 2020 ; 81 : 102766.
Alcohol Use Patterns and Liver Outcomes: Is There Really a Difference Between Drinking Beer and Drinking Wine? Clinical Gastroenterology and Hepatology 2020 ; 18 (7) : 1650-1651.
Application of Functional Data Analysis to Identify Patterns of Malaria Incidence, to Guide Targeted Control Strategies. International Journal of Environmental Research and Public Health 2020 ; 17 (11) : 4168. https://www.mdpi.com/1660-4601/17/11/4168
HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort). AIDS and Behavior 2020 ; 24 (4) : 1069-1084.
Correlates of Self-Reported Cotton Fever Experience among People Who Inject Opioids. Substance Use and Misuse 2020 ; 55 (6) : 1021-1027.
Screening and care for alcohol use disorder in France: expectations, barriers and levers using a mixed-methods approach. BMC Public Health 2020 ; 20 (1) : 358.
Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH). Journal of Hepatology 2020 ; 72 (3) : 588-591.
Cannabis Use and Plasma Human Immunodeficiency Virus (HIV) RNA Levels in Patients Coinfected With HIV and Hepatitis C Virus Receiving Antiretroviral Therapy: Data From the ANRS CO13 HEPAVIH Cohort. Clinical Infectious Diseases 2020 ; ciaa117 : Online ahead of print.
Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM). BMC Infectious Diseases 2020 ; 20 (1) : 49.
Patient-reported outcomes to enhance person-centred HIV care. Lancet HIV 2020 ; 7 (1) : e59-e68.
Population attributable fractions of mortality in people living with HIV: roles of delayed antiretroviral therapy, hepatitis coinfections and social factors. AIDS. Official journal of the international AIDS Society 2020 ; 34 (12) : 1843-1854.
Hepatitis C virus-microelimination program and patient trajectories after hepatitis C virus cure in an outpatient HIV clinical unit. European Journal of Gastroenterology & Hepatology 2020 ; 1.
Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS-FANTASIO study). Addiction 2019 ; 115 (3) : 573-582.
France removes hepatitis C treatment prescriber restrictions—But what is the impact of the delay for key populations? Liver International 2019 ; 39 (12) : 2418-2419.
Prevention and care of hepatitis B in the rural region of Fatick in Senegal : a healthcare workers’ perspective using a mixed methods approach. BMC Health Services Research 2019 ; 19 (1)
Methadone in primary care in France: Using evidence for action against hepatitis C. International Journal of Drug Policy 2019 ; 71 : 91-92.
Factors associated with virological rebound in HIV-positive sub-Saharan migrants living in France after traveling back to their native country -ANRS-VIHVO 2006-2009 study. Journal of Immigrant and Minority Health 2019 .
No influence of cannabis use on liver stiffness in HIV-HCV co-infected patients (ANRS CO13 HEPAVIH cohort study). European Journal of Gastroenterology & Hepatology 2019 ; 31 (2) : 274-276.
Therapeutic prospects of cannabidiol for alcohol use disorder and alcohol-related damages on the liver and the brain. Frontiers in Pharmacology 2019 ; 10 : 627.
Interventions to address substance use and sexual risk among gay, bisexual and other men who have sex with men who use methamphetamine: A systematic review. Drug and Alcohol Dependence 2019 ; 194 : 410-429.
Letter to the Editor: Patient-Reported Outcomes for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: Rationale for Expanded Use. Hepatology 2019 ; 70 (1) : 443-444.
Changes in supervised drug-injecting practices following a community-based educational intervention: A longitudinal analysis. Drug and Alcohol Dependence 2018 ; 192 : 1 - 7.
Wine Consumption and Lower Risk of Advanced Liver Fibrosis: A True Effect or Unmeasured Confounding? A Longitudinal Analysis (ANRS CO13 HEPAVIH Cohort). The American Journal of Gastroenterology 2018 ; 113 (11) : 1729-1732.
Barriers and levers in screening and care for alcohol use disorders among French general practitioners: results from a computer-assisted telephone interview-based survey. Alcoholism Treatment Quarterly 2018 ; 37 (2) : 207-224.
Profile, risk practices and needs of people who inject morphine sulfate: Results from the ANRS-AERLI study. International Journal of Drug Policy 2018 ; 59 : 3 - 9.
Clinical Features and Complications of Coxiella burnetii Infections From the French National Reference Center for Q Fever. JAMA Network Open 2018 ; 1 (4) : e181580.
Posttraumatic Stress Disorder as a Significant Correlate of Voluntary Antiretroviral Treatment Interruption in Adult HIV-Infected Patients Followed up in French Hospitals. Journal of Clinical Psychiatry 2018 ; 79 (3)
The need for patient-tailored dosing of baclofen in future clinical trials ☆. European Neuropsychopharmacology 2018 ; 28 (5) : 656-657.
Reply to: “Coffee consumption and decreased all-cause mortality – What is the true estimate of effect?”. Journal of Hepatology 2018 ; 68 (5) : 1106.
Gender, Alcohol Use, and Fibrosis in Human Immunodeficiency Virus/Hepatitis C Virus–Coinfected Individuals. Clinical Infectious Diseases 2018 ; 66 (6) : 983 - 984.
Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients. World journal of hepatology 2018 ; 10 (11) : 856-866.
Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe. Journal of Hepatology 2018 ; 68 (3) : 402-411.
Hepatitis C virus infection and hospital-related outcomes: a systematic review protocol. BMJ Open 2018 ; 8 (6) : e021118.
Factors associated with perceived loss of libido in people who inject opioids: Results from a community-based survey in France. Drug and Alcohol Dependence 2018 ; 190 : 121-127.
Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY 2018 ; 16 (5) : 377-380.
Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits. International Journal of Drug Policy 2018 ; 62 : 24-29.
Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial). The Patient - Patient-Centered Outcomes Research 2017 ; 10 (5) : 605 - 614.
Role of community-based research in advocating HCV prevention and care. Journal of the International AIDS Society 2017 ; 20 (2) : e25005.
Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort). Digestive Diseases and Sciences 2017 ; 62 (10) : 2943 - 2944.
Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort. Addiction 2017 ; 112 (9) : 1669-1679.
Thrombosis and antiphospholipid antibody syndrome during acute Q fever. Medicine 2017 ; 96 (29) : e7578.
Pain in methadone patients: Time to address undertreatment and suicide risk (ANRS-Methaville trial). PLoS ONE 2017 ; 12 (5) : e0176288.
No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort). Drug and Alcohol Review 2017 ; 36 (2) : 227-238.
Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT). Clinics and Research in Hepatology and Gastroenterology 2017 ; 41 (1) : 56 - 65.
The impact of coffee consumption on fibrosis and steatosis in HIV-HCV co-infected patients. Journal of Hepatology 2017 ; 68 : 840–866.
Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial). International Journal of Drug Policy 2017 ; 39 : 86-91.
Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France. Substance Abuse Treatment, Prevention, and Policy 2016 ; 12 (1) : 46.
Factors Associated with HIV Status Disclosure in HIV-Infected Sub-Saharan Migrants Living in France and Successfully Treated with Antiretroviral Therapy: Results from the ANRS-VIHVO Study. Journal of Immigrant and Minority Health 2016 ; [Epub ahead of print].
Antiphospholipid Antibody Syndrome With Valvular Vegetations in Acute Q Fever. Clinical Infectious Diseases 2016 ; 537-44.
Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study). Harm Reduction Journal 2015 ; 13 (1) : 12.
Insufficient access to harm reduction measures in prisons in 5 countries (PRIDE Europe): a shared European public health concern. BMC Public Health 2015 ; 15 (1) : 1093.
Suicidal risk among patients enrolled in methadone maintenance treatment: HCV status and implications for suicide prevention (ANRS Methaville). Comprehensive Psychiatry 2015 ; 62 : 123-131.
Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy (ART): the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohort. Antiviral Therapy 2015 ; 20 (7) : 763--772.
Methadone Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville). PLoS ONE 2014 ; 9 (11) : 112328 - 112328.
Predictors of non-prescribed opioid use after one year of methadone treatment: An attributable-risk approach (ANRS-Methaville trial). Drug and Alcohol Dependence 2014 ; 135 : 1-8.
Impact of HCV treatment and depressive symptoms on adherence to HAART among coinfected HIV-HCV patients: results from the ANRS-CO13-HEPAVIH cohort. Antiviral Therapy 2014 ; 19 (2) : 171-8.
De jure decriminalisation of cannabis use matters: some recent trends from France. International Journal of Drug Policy 2013 ; epub ahead of print.
Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial. BMC Public Health 2012 ; 12 (1) : 488.
Limited access to HIV prevention in French prisons (Anrs-Pri2de): implications for public health and drug policy. BMC Public Health 2011 ; 11 (1) : 400.
Non-medical use of opioids among HIV-infected opioid dependent individuals on opioid maintenance treatment: the need for a more comprehensive approach. Harm Reduction Journal 2011 ; 8 (1) : 31.
Quality of life assessment in HIV clinical research in resource-limited settings: better late than never. Tropical Medicine and International Health 2010 ; 15 (9) : 1008-1010.
Desire for a child among HIV-infected women receiving antiretroviral therapy in Cameroon: results from the national survey EVAL (ANRS 12-116). AIDS Care 2010 ; 22 (04) : 441-451.
Psychosocial correlates of inconsistent condom use among HIVinfected patients enrolled in a structured ART interruptions trial in Coˆ te d’Ivoire: results from the TRIVACAN trial (ANRS 1269). Tropical Medicine and International Health 2010 .
Réduction des risques infectieux Chez les usagers de drogues. 2010 ; Les éditions Inserm, ISSN 1264-1782.
Impaired Anger Control as an Underappreciated Side Effect of Treatments for Chronic HCV Infection in HIV-HCV Coinfected Patients. Journal of Clinical Gastroenterology 2008 ; 42 : 92 - 96.
Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment. Antiviral Therapy 2008 ; 13 (5) : 697-703.
Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). International Journal of Drug Policy 2007 ; 18 (4) : 262-70.
Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8). International Journal of Drug Policy 2007 ; 18 (4) : 288-95.
Do migrants overreport adherence to highly active antiretroviral therapy?: results from the French VESPA (ANRS-EN12) National Survey. Journal of Acquired Immune Deficiency Syndromes - JAIDS 2006 ; 42 (5) : 646-7.